Sangamo Therapeutics Statistics
Total Valuation
SGMO has a market cap or net worth of $122.43 million. The enterprise value is $122.13 million.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SGMO has 237.60 million shares outstanding. The number of shares has increased by 19.33% in one year.
| Current Share Class | 237.60M |
| Shares Outstanding | 237.60M |
| Shares Change (YoY) | +19.33% |
| Shares Change (QoQ) | +4.80% |
| Owned by Insiders (%) | 1.35% |
| Owned by Institutions (%) | 22.26% |
| Float | 231.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.71 |
| Forward PS | 1.52 |
| PB Ratio | 23.67 |
| P/TBV Ratio | 24.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of 5.07.
| Current Ratio | 0.76 |
| Quick Ratio | 0.60 |
| Debt / Equity | 5.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.91 |
Financial Efficiency
Return on equity (ROE) is -257.94% and return on invested capital (ROIC) is -86.10%.
| Return on Equity (ROE) | -257.94% |
| Return on Assets (ROA) | -46.95% |
| Return on Invested Capital (ROIC) | -86.10% |
| Return on Capital Employed (ROCE) | -220.73% |
| Revenue Per Employee | $348,393 |
| Profits Per Employee | -$434,148 |
| Employee Count | 183 |
| Asset Turnover | 0.59 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -146,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.27% in the last 52 weeks. The beta is 1.21, so SGMO's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -10.27% |
| 50-Day Moving Average | 0.62 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 45.31 |
| Average Volume (20 Days) | 4,967,709 |
Short Selling Information
The latest short interest is 31.91 million, so 13.43% of the outstanding shares have been sold short.
| Short Interest | 31.91M |
| Short Previous Month | 28.25M |
| Short % of Shares Out | 13.43% |
| Short % of Float | 13.80% |
| Short Ratio (days to cover) | 6.30 |
Income Statement
In the last 12 months, SGMO had revenue of $63.76 million and -$79.45 million in losses. Loss per share was -$0.38.
| Revenue | 63.76M |
| Gross Profit | -37.88M |
| Operating Income | -80.80M |
| Pretax Income | -248.51M |
| Net Income | -79.45M |
| EBITDA | -76.08M |
| EBIT | -80.80M |
| Loss Per Share | -$0.38 |
Full Income StatementBalance Sheet
The company has $25.18 million in cash and $24.88 million in debt, giving a net cash position of $304,000 or $0.00 per share.
| Cash & Cash Equivalents | 25.18M |
| Total Debt | 24.88M |
| Net Cash | 304,000 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | 4.91M |
| Book Value Per Share | 0.02 |
| Working Capital | -11.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$44.63 million and capital expenditures -$267,000, giving a free cash flow of -$44.89 million.
| Operating Cash Flow | -44.63M |
| Capital Expenditures | -267,000 |
| Free Cash Flow | -44.89M |
| FCF Per Share | -$0.19 |
Full Cash Flow StatementMargins
Gross margin is -59.41%, with operating and profit margins of -126.73% and -124.61%.
| Gross Margin | -59.41% |
| Operating Margin | -126.73% |
| Pretax Margin | -124.84% |
| Profit Margin | -124.61% |
| EBITDA Margin | -119.32% |
| EBIT Margin | -126.73% |
| FCF Margin | n/a |
Dividends & Yields
SGMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.33% |
| Shareholder Yield | -19.33% |
| Earnings Yield | -64.89% |
| FCF Yield | -36.67% |
Analyst Forecast
The average price target for SGMO is $4.50, which is 773.28% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.50 |
| Price Target Difference | 773.28% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 37.50% |
| EPS Growth Forecast (5Y) | -24.96% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGMO has an Altman Z-Score of -25.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.85 |
| Piotroski F-Score | 3 |